Profil
Luciano D'Adamio is the founder and chairman of RemeGenix, Inc. which is founded in 2006.
He is also the founder of Kappa Lifescience Ltd.
and Sienagen S R L.
Currently, he holds the position of Professor-Immunology & Microbiology at Albert Einstein College of Medicine, Inc.
Postes actifs de Luciano D'Adamio
| Sociétés | Poste | Début |
|---|---|---|
| REMEGENIX, INC. | Fondateur | 28/04/2006 |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | - |
Anciens postes connus de Luciano D'Adamio
| Sociétés | Poste | Fin |
|---|---|---|
| Sienagen S R L | Fondateur | - |
| Kappa Lifescience Ltd. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
RemeGenix, Inc.
 RemeGenix, Inc. Pharmaceuticals: MajorHealth Technology RemeGenix, Inc. is a biotechnology company, which engages in the development of drug MoBA which is used for treatment of Alzheimer's disease. Its product pipe lines include NoMAD, which is one of the preferred animal models used in the development of a variety of Alzheimer's and ementia drug development efforts and MoBA. The company was founded by Luciano D'Adamio and J. Kelly Ganjei on April 28, 2006 and is headquartered in Bethesda, MD. | Health Technology |
| Kappa Lifescience Ltd. | |
| Sienagen S R L |